GENERAL INFORMATION
Established:  2000
Ownership:  Private
Parent:  MDG MEDICAL Inc.

Core business

A developer of computerized medication administration systems for
use in hospitals and other health care institutions

Employees:  65
Main Markets:  Healthcare Institutions

Overview

MDG MEDICAL LTD. is a research and development subsidiary in
Israel of MDG Medical Inc., based in Cleveland, Ohio, USA.

MDG Medical develops technology that helps prevent medication
error in hospitals and other medical institutions. MDG's flagship
product is ServeRx, a system that reduces human error in
medication distribution and improves both the efficiency of
medical staff and the management of hospital pharmaceutical
supplies.

ServeRx is already in use at the Sheba Medical Center, the
largest medical center in the Middle East, which serves as the
system's first worldwide beta site location. The system is also
in use at the Sourasky Medical Center, the third largest hospital
in Israel, and at the Hammersmith Hospital Trust in London, one
of Europe's leading hospitals. Over the coming months the ServeRx
system will be installed in additional hospitals throughout
Israel, Europe and the United States.

Thousands of people die and tens of thousands more are injured
each year due to preventable medication errors. These errors,
including patient mixups, illegible prescriptions, confusion
between different pharmaceuticals with similar names, and
incorrect dosages, cause deep human suffering. For health-care
institutions, preventable medication errors lengthen patients'
hospital stays and create millions of dollars of additional
operating expenses and liability costs.

Adverse drug events (ADEs) occur at a rate of 2.5% of hospital
admissions in the U.S. and 10% in Europe. Each of these ADEs
costs hospitals an average of nearly $5,000. Worldwide,
legislators and the public at large are demanding that
health-care institutions take affirmative steps to better manage
their medication efforts and protect their patients.